Lymeless offers Ella, an AI‑driven virtual health companion that guides Lyme disease patients through discovery, treatment, and maintenance phases. The platform provides personalized education, evidence‑based treatment suggestions, and real‑time symptom and medication tracking, consolidating medical records into a unified timeline for easy sharing with clinicians.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with Lyme disease often struggle to obtain accurate, personalized information about their condition, leading to delayed diagnoses, inconsistent treatment plans, and difficulty tracking symptom progression over time.
Solution
Lymeless provides Ella, an AI‑driven virtual health companion that guides users through each stage of their Lyme disease journey—from initial discovery to treatment and long‑term maintenance. Ella delivers Lyme‑specific educational content, suggests evidence‑based treatment options, and offers real‑time symptom tracking to generate actionable care insights. The platform consolidates medical records, test results, and medication schedules into a unified timeline, enabling users to monitor progress and share concise updates with healthcare providers. By combining AI‑powered guidance with precision tracking, Ella helps patients make informed decisions and stay engaged with their care plan.
Target Audience
Primary users are individuals diagnosed with Lyme disease or experiencing persistent Lyme‑related symptoms who seek a structured, self‑managed approach to treatment and monitoring.
Features
- AI chatbot that answers Lyme‑specific questions and provides personalized health recommendations
- Symptom and medication logging tools that generate visual trend charts and care insights
- Integrated medical timeline that aggregates test results, appointments, and treatment milestones
- Treatment management module that aligns user data with current Lyme disease guidelines
- Secure data storage with easy export options for sharing with clinicians